RxDoctor Payments Data

Candice Midkiff

Family · Bossier City, LANPI 1154054492

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $653, more than ten times the $18 reported in 2022.

$961in general payments, 2019–2025

Across 49 payments — averaging $19.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$208
  • Novo Nordisk$150
  • AstraZeneca$141
  • Axsome Therapeutics, Inc.$79
  • Otsuka America Pharmaceutical, Inc.$58
  • Boehringer Ingelheim$57
  • plus $268 from 8 others

What the payments were for

  • Food & beverage$961100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$961 in reported general payments places this provider in the 60th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana →

Medicare billing

Part B allowed, 2024
$36,446
Medicare patients
222
Services billed
1,446

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate16$400
Doxycycline Hyclate38$240
Duloxetine Hcl16$219
Methylprednisolone18$154
Atorvastatin Calcium24$140
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$139
Triamcinolone Acetonide14$104
Gabapentin14$100
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst11$94
Prednisone72$88
Azithromycin28$87
Metformin Hcl13$73
Mupirocin12$72
Amoxicillin18$54
Meloxicam17$36

Paid to pharmacies, not to this prescriber.

Other family in Bossier City

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →